BioLineRx (BLRX) Invested Capital (2023 - 2025)
Historic Invested Capital for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $4.5 million.
- BioLineRx's Invested Capital fell 5439.83% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year decrease of 3363.0%. This contributed to the annual value of $4.5 million for FY2024, which is 4241.65% up from last year.
- As of Q3 2025, BioLineRx's Invested Capital stood at $4.5 million, which was down 5439.83% from $4.5 million recorded in Q2 2025.
- BioLineRx's Invested Capital's 5-year high stood at $10.7 million during Q2 2024, with a 5-year trough of $2.6 million in Q1 2023.
- Its 3-year average for Invested Capital is $4.9 million, with a median of $4.5 million in 2024.
- In the last 5 years, BioLineRx's Invested Capital soared by 24619.88% in 2024 and then crashed by 5796.73% in 2025.
- Over the past 3 years, BioLineRx's Invested Capital (Quarter) stood at $3.1 million in 2023, then soared by 42.42% to $4.5 million in 2024, then changed by 0.0% to $4.5 million in 2025.
- Its last three reported values are $4.5 million in Q3 2025, $4.5 million for Q2 2025, and $4.7 million during Q1 2025.